Onward Medical N.V. (EBR:ONWD)
4.060
-0.090 (-2.17%)
Nov 19, 2025, 4:35 PM CET
Onward Medical Revenue
Onward Medical had revenue of 1.19M EUR in the half year ending June 30, 2025, with 27.69% growth. This brings the company's revenue in the last twelve months to 2.72M, down -1,544.68% year-over-year. In the year 2024, Onward Medical had annual revenue of 1.74M with 226.88% growth.
Revenue (ttm)
2.72M
Revenue Growth
-1,544.68%
P/S Ratio
68.28
Revenue / Employee
26.37K
Employees
103
Market Cap
185.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.74M | 1.21M | 226.88% |
| Dec 31, 2023 | 532.00K | -1.62M | -75.23% |
| Dec 31, 2022 | 2.15M | 749.00K | 53.54% |
| Dec 31, 2021 | 1.40M | 599.00K | 74.88% |
| Dec 31, 2020 | 800.00K | 246.00K | 44.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 6.85B |
| argenx SE | 3.14B |
| Fagron NV | 918.75M |
| Ion Beam Applications | 585.76M |
| European Medical Solutions | 49.47M |
| Biocartis Group NV | 47.69M |
| Hyloris Pharmaceuticals | 8.46M |
| Nyxoah | 5.64M |
Onward Medical News
- 2 days ago - ONWARD Medical Secures FDA Clearance For ARC-EX System Home Use - Nasdaq
- 5 weeks ago - Onward Medical Posts Preliminary Q3 Revenue Of Over EUR 1 Mln - Nasdaq
- 2 months ago - ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal ... - GuruFocus
- 2 months ago - Onward Medical N.V. (ONWRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Onward Medical N.V. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 months ago - ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its ... - GuruFocus
- 1 year ago - Onward Medical N.V. reports 1H results - Seeking Alpha